Ibogaine and SUD Treatment: Signal, Risk, and the Role of Providers
Providers don’t need to endorse ibogaine treatment to take this moment seriously. They need to understand it, respect the risk, and prepare for those already seeking it.
Providers don’t need to endorse ibogaine treatment to take this moment seriously. They need to understand it, respect the risk, and prepare for those already seeking it.
Given the scale of the pediatric overdose crisis, medical students must receive early and consistent training on how to screen for substance use and engage in overdose prevention during pediatric encounters.
As the safety-net landscape shifts and funding uncertainty grows, the path forward is clear. By investing in highly coordinated, data-informed care and aligning health plans, providers and communities around shared goals, we can build a system that reaches individuals with complex care needs, supports whole-person health initiatives and strengthens care across the board.
Technology has the power to revolutionize treatment, make it more widely available, provide additional patient insight, and ultimately, alleviate the strain on our already stressed healthcare system.
We must consider the broader social and structural context — recognizing that poverty, social deprivation, and economic instability are not merely relevant factors, but necessary considerations in developing effective, equitable interventions.
How marketing can help patients find a treatment center that can address their long-term care needs
Trump officials argue that current regulation has not kept up with the times and the necessity of coordinated approaches to addressing the opioid epidemic.
DynamiCare's approach is based on a behavioral therapy called Contingency Management, which uses positive reinforcement to change behavior
With the new funding, MAP Health Management is hoping to more than double the states it operates in and move upstream to other sites of care to help treat substance abuse before it worsens.